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A
fibrinogenemia is a rare coagulation deficiency, inher-
ited as an autosomal recessive trait. It can be manifested
in homozygotes or compound heterozygotes by a severe
bleeding tendency caused by deficiency of fibrinogen (factor I).
The estimated prevalence in Italy is about 1:1,000,000, and
0.2% of the patients with a coagulation deficiency in the United
Kingdom have afibrinogenemia1,2. In Switzerland, nine patients
are listed in the national hemophilia registry.
Among severe bleeding symptoms, umbilical cord bleed-
ing is the most frequent and life-endangering event3. Intracra-
nial hemorrhage is the major cause of death and is the primary
reason for prophylaxis. Less severe findings, such as sponta-
neous muscle hematomas, epistaxis, and menorrhagia, are also
frequent3.
Patients with afibrinogenemia have remarkably fewer
spontaneous hemarthroses in contrast to better known bleeding
disorders such as hemophilia A and hemophilia B3-6.
We report the case of a patient with congenital afibrino-
genemia who had severe elbow arthropathy and was treated
with a total elbow arthroplasty. The patient was informed that
data concerning the case would be submitted for publication,
and he consented.
Case Report
Aforty-seven-year-old man was referred to our institutionwith a severe arthropathy of the left, nondominant elbow.
Afibrinogenemia was diagnosed at birth. For many years, he was
administered 4 g of Haemocomplettan HS (human fibrinogen;
CSL Behring, Bern, Switzerland) intravenously every two weeks.
The causative mutation in his family (the parents were non-
consanguineous, and his brother and two cousins were also
affected) was identified as a homozygous deletion of approxi-
mately 11 kb of the fibrinogen alpha chain gene7. Over the
years, the left elbow became increasingly symptomatic sec-
ondary to recurrent hemarthroses. The elbow was always the
primary joint involved, although mild osteoarthritic changes
were noted in the ankles. In 1991, at the age of thirty-one years,
he had an open elbow synovectomy, which decreased the fre-
quency of joint bleeding substantially.
The elbow remained minimally symptomatic until 2006,
when the patient was forty-six years old, and he presented with
pain at rest, severe activity-related pain, and night pain. He also
had difficulty performing the activities of daily living. Never-
theless, he was able to work full time in his profession as a
telematics technician. Physical examination revealed a mild
effusion. Range of motion was painful and severely limited, with
flexion to 80 and a 45 extension loss. Forearm rotation was
also painful and mildly limited. There were no neurologic
deficits. The preoperative Mayo Elbow Performance Score8 was
40 points (15 points for pain, 5 points for motion, 10 points
for stability, and 10 points for function).
Biplanar radiographs of the elbow showed severe de-
generative arthritis according to the modified Arnold and
Hilgartner classification of hemophiliac arthropathy (Fig. 1)9.
Because joint salvage procedures such as arthroscopic or open
de´bridement did not seem promising, a total elbow arthro-
plasty with use of a semiconstrained Coonrad-Morrey pros-
thesis (Zimmer, Warsaw, Indiana) was performed in 2006.
Preoperatively, intraoperatively, and postoperatively, the pa-
tient was closely monitored and fibrinogen was administered
under the supervision of a hematologist. Prior to anesthesia,
the patient received 4 g of Haemocomplettan HS. This was his
usual dose, given every two weeks, and was known to increase
the fibrinogen level to >1 g/L.
At the time of surgery, the elbow joint was approached
through a straight posterior incision. The ulnar nerve was ex-
posed and mobilized, and at the end of the procedure it was
transposed anteriorly. The triceps was reflected from the tip of
the olecranon in a medial to lateral dissection with use of the
technique described by Morrey et al.10. The joint was very
contracted, and the radial head was resected to gain better
exposure and adequate visualization. All of the joint surfaces
showed complete loss of articular cartilage and eburnation of
the bone. After humeral and ulnar preparation, the compo-
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nents were implanted simultaneously with use of bone cement
fixation. At the end of the procedure, flexion was 140 and loss
of extension was 10. The triceps was reattached to the olec-
ranon11. The postoperative radiographs showed proper posi-
tioning of the implant.
During surgery and in the early postoperative period, our
aim was to maintain a permanent level of fibrinogen of 0.5 g/L.
Therefore, 1 g of Haemocomplettan HS was administered in-
travenously every day, and the fibrinogen level was checked
every other day.
There were no early or late postoperative complications,
including nerve palsy or major bleeding.
Postoperatively, the elbow was immobilized in an anterior
splint in full extension. From the second postoperative day, free
active-assisted and passive mobilization of the elbow was al-
lowed. On the fourth postoperative day, there was deep wound
bleeding with slight swelling of the elbow, which did not affect
the postoperative course. The fibrinogen level was 0.3 g/L.
The patient was hospitalized for ten days to closely
monitor bleeding and fibrinogen levels. For the first six weeks
postoperatively, 2 g of Haemocomplettan HS was given twice
a week; then 3 g was given weekly for another twelve weeks
before returning to the preoperative scheme of 4 g of Haemo-
complettan HS every two weeks. Fibrinogen levels (a minimum
of 0.3 g/L and a peak at a maximum of 1.4 g/L) were checked
with every change of dose.
During this eighteen-week period, the patient received
thromboprophylaxis with 5000 IU of low-molecular-weight
heparin. We were very cautious because of the thromboembolic
events in his family as well as case reports about thromboem-
bolism in afibrinogenic patients and therefore chose this long
period of prophylaxis.
By six months, the range of motion had plateaued with
flexion of 135, loss of extension of 30, and full forearm ro-
tation. At the one and two-year follow-up visits, the patient was
very satisfied with the result and there was no loss of range of
motion. Two years after surgery, the range of motion of the left
elbow was unchanged compared with that at the time of the six-
month follow-up. This is comparable with the results reported
by Kamineni et al.12 and Chapman-Sheath et al.13. The patient
was free of pain and able to perform all activities of daily living.
The Mayo Elbow Performance Score was 95 points. Radio-
graphs made two years postoperatively showed a satisfactory
position of the implant with no signs of loosening.
Discussion
Afibrinogenemia is a rare hereditary coagulation disorderdue to defects in the Aa, Bb, or g chains of fibrinogen,
resulting in malfunction in the formation of cross-linked fibrin
clots in the final common pathway of both the extrinsic and
intrinsic blood-clotting cascades. Recently, genetic studies have
substantially increased our understanding of the underlying
Fig. 1
Preoperative anteroposterior and lateral radiographs showing the severe arthropathic changes of the left elbow
with advanced joint-space narrowing on the ulnar side, complete collapse on the radial side, as well as substantial
elbow deformity, especially of the radial head with large osteophytes. This is an example of stage-III to IV ar-
thropathy, according to the modified Arnold and Hilgartner classification of hemophilic arthropathy.
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molecular defects in afibrinogenemia; however, optimum treat-
ment is not as well established as it is for hemophilia A and B
because of the limited number of cases1,14,15.
Compared with more common coagulation disorders,
such as hemophilia A and B, some clinical manifestations, such
as muscle hematomas, epistaxis, or central nervous system
bleeding, are as frequent, whereas spontaneous hemarthroses
are rare in afibrinogenemia3-6. In hemophilia, arthropathy has
been well described, with the elbow being the second most
commonly affected joint besides the knee. To our knowledge,
this is not only the first reported case of severe elbow arthrop-
athy in a patient with afibrinogenemia but it appears to be
the first reported case of a patient with severe arthritic joint
involvement in this disease. The exact pathogenesis of ar-
thropathy in afibrinogenemia is unknown. It is known that
in hemophilia the pathogenesis is multifactorial and includes
cartilage-mediated as well as inflammatory synovium-mediated
components, resulting in a fibrotic and destroyed joint as in
the patient reported here16.
The cases of only a few patients with a coagulation dis-
order who had arthropathy and were managed with a total
elbow arthroplasty are documented in the literature12,13.
Kamineni et al. reported on five patients with hemophilic ar-
thropathy who were treated with a linked, semiconstrained
total elbow replacement. Two of the five patients had severe
complications (uncontrollable hemorrhage in one and a deep
wound infection in both patients), and one patient had a
minor complication (recurrent intra-articular hemorrhages).
At a mean follow-up of 122 months, the patients had improved
substantially in terms of pain compared with preoperatively.
Elbow range of motion was also substantially improved at the
time of the final evaluation. The postoperative Mayo Elbow
Performance Score was 90 points, clearly showing an increase
compared with the score of 24 points preoperatively12. In an-
other study, Chapman-Sheath et al. reported on seven total
elbow replacements in five patients with hemophilia13. They
described major complications in three patients, including
ulnar nerve palsy, axillary vein thrombosis, and septic loos-
ening of the arthroplasty components in one patient each. The
mean postoperative range of motion was 122 of flexion and
an extension loss of 28.5 at a mean follow-up of forty-two
months. The results are comparable with those in our patient,
in whom flexion improved to 135 with an extension loss of
30, an arc of motion that is sufficient to perform all of the
activities of daily living17. In patients with joint hemophilia,
contractures are very common, resulting from recurrent intra-
articular and intramuscular bleeding episodes. Correction of
hemophilic contractures during total joint replacement can be
very challenging; therefore, restoration of unlimited activities
of daily living, rather than the achievement of anatomic or
radiographic normality, is the primary goal18.
Because of the repetitive bleeding episodes and the
similar radiographic appearance of the arthropathy, we hy-
pothesize a close similarity between the development of ar-
thropathy in patients with hemophilia and in patients with
afibrinogenemia. As in all bleeding disorders, patients with
afibrinogenemia require a multidisciplinary team approach
with close cooperation of the surgeon with a hematologist
specialized in coagulation disorders. n
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